Workflow
Precision Drilling(PDS)
icon
Search documents
Precision Drilling (PDS) Tops Q2 Earnings and Revenue Estimates
ZACKS· 2025-07-30 01:01
Core Viewpoint - Precision Drilling reported quarterly earnings of $0.77 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.02 per share, although this is a decrease from $1.05 per share a year ago, indicating a substantial earnings surprise of +3,950.00% [1] Group 1: Earnings and Revenue Performance - The company posted revenues of $293.87 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.15%, but down from $313.7 million year-over-year [2] - Over the last four quarters, Precision Drilling has surpassed consensus EPS estimates two times and topped consensus revenue estimates just once [2] Group 2: Stock Performance and Outlook - Precision Drilling shares have declined approximately 12.7% since the beginning of the year, contrasting with the S&P 500's gain of 8.6% [3] - The company's earnings outlook will be crucial for future stock performance, with current consensus EPS estimates at $1.00 for the coming quarter and $3.89 for the current fiscal year [7] Group 3: Industry Context - The Oil and Gas - Drilling industry is currently ranked in the bottom 5% of over 250 Zacks industries, which may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5][6]
Precision Drilling Announces 2025 Second Quarter Unaudited Financial Statements
Globenewswire· 2025-07-29 22:39
Core Viewpoint - Precision Drilling Corporation reported stronger than anticipated financial and operational results for the second quarter of 2025, driven by excellent free cash flow, new contracts, and strong demand for its Super Series rig fleet [2][5][21]. Financial Highlights - Revenue for Q2 2025 was $407 million, a decrease of 5.3% from $429 million in Q2 2024, primarily due to lower U.S. and international activity [6][14]. - Adjusted EBITDA was $108 million, down 6.1% from $115 million in the same quarter last year, with a consistent EBITDA margin of 27% [6][21]. - Net earnings attributable to shareholders were $16 million or $1.21 per share, compared to $21 million or $1.44 per share in Q2 2024, marking the 12th consecutive quarter of positive earnings [5][21]. - Cash provided by operations was $147 million, allowing the company to repay $74 million of debt and repurchase $14 million of common shares [7][21]. Operational Highlights - The average number of active drilling rigs in Canada was 50, slightly up from 49 in Q2 2024, while U.S. active rigs averaged 33, down from 36 [8][16]. - Canadian revenue per utilization day increased to $37,725 from $36,075 year-over-year, driven by customer-funded rig upgrades [6][21]. - U.S. revenue per utilization day decreased to $31,113 from $33,227, reflecting lower industry activity [6][21]. - International operations generated $36 million in revenue with seven active rigs, down from eight in Q2 2024 [10][21]. Strategic Initiatives - The company revised its 2025 capital budget to $240 million from $200 million to support upgrades of 22 Super Series rigs, responding to increased customer demand [12][26]. - Precision aims to maximize free cash flow through disciplined capital deployment and enhance shareholder returns via debt reduction and share repurchases [22][26]. - The company is positioned to further adjust capital spending based on evolving customer demand, with a focus on technological advancements in its rig fleet [12][22]. Market Outlook - In Canada, increased takeaway capacity from the Trans Mountain pipeline expansion is expected to support heavy oil activity, while LNG Canada’s first shipment is anticipated to drive demand for Super Triple rigs [27][30]. - In the U.S., natural gas drilling is expected to increase as customers become more optimistic about LNG off-take and AI demand, with a focus on natural gas basins like Haynesville and Marcellus [28][30]. - Internationally, the company maintains a steady level of activity with five rigs in Kuwait and two in Saudi Arabia, under long-term contracts extending into 2027 and 2028 [10][29].
Analysts Estimate Precision Drilling (PDS) to Report a Decline in Earnings: What to Look Out for
ZACKS· 2025-07-22 15:07
Core Viewpoint - The market anticipates a year-over-year decline in earnings for Precision Drilling due to lower revenues, with a focus on how actual results compare to estimates [1][3]. Earnings Expectations - Precision Drilling is expected to report a quarterly loss of $0.02 per share, reflecting a significant year-over-year change of -101.9% [3]. - Revenues are projected to be $290.53 million, which is a decrease of 7.4% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 16.67% lower in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate aligns with the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [12]. Earnings Surprise Prediction - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [10]. - Precision Drilling currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [12][13]. Historical Performance - In the last reported quarter, Precision Drilling was expected to post earnings of $1.57 per share but delivered $1.53, resulting in a surprise of -2.55% [14]. - Over the past four quarters, the company has beaten consensus EPS estimates two times [15]. Market Reaction - The stock may rise if earnings exceed expectations, while a miss could lead to a decline [2]. - Other factors beyond earnings results can also influence stock movement, making it essential to consider various elements before making investment decisions [16][18].
Precision Drilling Corporation 2025 Second Quarter Results Conference Call and Webcast
Globenewswire· 2025-07-02 20:00
Company Overview - Precision Drilling Corporation is a leading provider of safe and environmentally responsible services to the energy industry, offering access to an extensive fleet of Super Series drilling rigs [4] - The company has commercialized an industry-leading digital technology portfolio known as Alpha™, which utilizes advanced automation software and analytics to deliver efficient, predictable, and repeatable results for energy customers [4] - Precision also provides well service rigs, camps, and rental equipment, supported by a comprehensive mix of technical support services and skilled personnel [4] Upcoming Financial Results - Precision intends to release its 2025 second quarter results after the market closes on Tuesday, July 29, 2025 [1] - A conference call is scheduled for 11:00 a.m. MT (1:00 p.m. ET) on Wednesday, July 30, 2025, to discuss the results [1] - Participants can register for the conference call to receive a dial-in number and unique PIN for questions [1] Webcast and Replay - The conference call will also be webcast, and a replay will be available on Precision's website for 12 months [2]
Precision Drilling (PDS) Earnings Call Presentation
2025-06-25 07:17
Financial Highlights - Precision Drilling anticipates a free cash flow yield potential of approximately 25% in 2025[11] - Analyst estimates for 2025 free cash flow are $226 million, against an equity market cap of $937 million, resulting in an estimated FCF yield of 24%[12] - The company aims to reduce total debt by at least $100 million in 2025[19] - A long-term debt reduction target has been increased to $700 million from 2022-2027, with $452 million already paid as of March 31, 2025[23] Operational Performance - Precision Drilling is the 1 land driller in Canada with 98 highly desirable rigs and a top land driller in the US with 104 rigs (66 Super Spec)[9] - The company is also the 1 well service provider in Canada with 153 rigs[9] - Canadian day rate margins have increased by 67% over the last 3 years[51] - US day rate margins have increased by over 60% in the last 3 years[66] Strategic Priorities - Maximize free cash flow and enhance shareholder returns are key strategic priorities for 2025[18] - The company plans to allocate 35%-45% of free cash flow to share repurchases in 2025 and is moving towards 50% of free cash flow for direct shareholder returns[19] - The company is focused on growing revenue in existing service lines through disciplined capital deployment, strict cost management, and opportunistic consolidating tuck-in acquisitions[19, 20]
Oil & Gas Drilling Is Struggling - But These 3 Names Stand Out
ZACKS· 2025-06-18 13:25
Industry Overview - The Zacks Oil and Gas - Drilling industry includes companies providing rigs and services for oil and natural gas exploration and development, with operations both onshore and offshore [2] - Drilling for hydrocarbons is capital-intensive and technically challenging, primarily influenced by contracting activity rather than oil or gas prices [2] - Offshore drilling companies exhibit higher volatility compared to onshore counterparts, with their share prices more closely correlated to oil and gas prices [2] Current Challenges - The industry is facing significant challenges due to contracting delays, soft gas prices, and macroeconomic uncertainty, leading to a Zacks Industry Rank of 235, placing it in the bottom 4% of 245 Zacks industries [1][7] - Earnings estimates for the industry have declined sharply, with a drop of 85.2% for 2025 and 51.7% for 2026 over the past year, indicating a negative outlook [9] - The industry has underperformed compared to the broader Zacks Oil - Energy sector and the S&P 500, with a decline of 38.6% over the past year versus a 2.1% increase in the sector and a 9.1% gain in the S&P 500 [11] Market Trends - Macroeconomic uncertainty is causing hesitation in customer decision-making, slowing the pace of tenders and contract awards, and making near-term earnings visibility difficult for drillers [3] - There are concerns about premature rig reactivation leading to oversupply, particularly in deepwater segments, which could undermine pricing power and margins [4] - Despite short-term challenges, long-term demand for deepwater drilling is expected to grow, with forecasts indicating a 40% increase in investment by 2030, supported by large undeveloped reserves and major project approvals [5] Company Highlights - **Transocean Ltd. (RIG)**: Reported contract drilling revenues of $906 million in Q1 2025, an 18.7% increase year-over-year, with a market capitalization of $2.9 billion and a projected earnings growth of 123.1% for 2025 [18] - **Patterson-UTI Energy (PTEN)**: Generated $51 million in adjusted free cash flow in Q1 2025, with a market capitalization of $2.5 billion and a dividend yield of nearly 5% [21] - **Precision Drilling Corporation (PDS)**: Canada’s largest drilling rig contractor, with a market capitalization of $687.3 million, has seen its earnings estimate for 2025 increase from $3.84 to $4.13 per share in the past 60 days [24]
PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC
GlobeNewswire News Room· 2025-06-09 12:00
Core Viewpoint - PDS Biotechnology Corporation is hosting a virtual event to discuss the evolving treatment landscape for recurrent/metastatic HPV16-positive head and neck squamous cell carcinoma (HNSCC) in light of the Merck KEYNOTE-689 study and the rising incidence of HPV16-positive HNSCC in the US and Europe [1][2]. Company Overview - PDS Biotechnology is a late-stage immunotherapy company focused on innovative treatments that enhance the immune system's ability to target and eliminate cancers [7]. - The company's lead investigational therapy, Versamune® HPV, is currently in a Phase 3 clinical trial in combination with pembrolizumab for first-line treatment of recurrent/metastatic HPV16-positive HNSCC [2][7]. Event Details - The event will feature key opinion leaders, including Kevin Harrington and Katharine A. Price, who will discuss the unmet needs in treating HPV16-positive HNSCC and the distinct characteristics of HPV-positive versus HPV-negative HNSCC [1][2][3]. - A live Q&A session will follow the formal presentations, allowing for direct engagement with the experts [3]. Clinical Trials and Research - Versamune® HPV is being evaluated in multiple clinical trials, including a Phase 3 trial in combination with pembrolizumab and Phase 2 trials for various HPV16-positive cancers [2]. - The event will also address the emerging treatment landscape for first-line recurrent/metastatic HNSCC and the differentiation between HPV-positive and HPV-negative cases [2]. Speakers' Expertise - Kevin Harrington is a leading authority on metastatic head and neck cancer and has significant experience in clinical trials related to HNSCC treatments [4]. - Katharine A. Price specializes in head and neck cancers and is involved in research aimed at improving treatment access and awareness regarding HPV vaccination [5].
Precision Drilling: Oilfield Activity In Canada Appears Resilient, So Far
Seeking Alpha· 2025-05-27 17:00
Group 1 - The articles express personal opinions and do not constitute investment recommendations [2][3] - The authors have disclosed beneficial long positions in specific stocks, indicating potential bias [1] - There is an emphasis on the importance of performing due diligence before making investment decisions [2][3] Group 2 - Past performance is highlighted as not being a guarantee of future results, which is a common disclaimer in investment analysis [3] - The platform does not act as a licensed securities dealer or investment adviser, indicating that the information provided is for informational purposes only [3]
Precision Drilling Corporation Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
GlobeNewswire News Room· 2025-05-15 21:00
Core Points - Precision Drilling Corporation successfully elected all eight nominee directors at its 2025 Annual and Special Meeting of Shareholders, with seven being independent [1] - The voting results showed high approval rates for the nominee directors, with William T. Donovan receiving 97.27% of votes in favor and Lori A. Lancaster receiving 98.62% [2] - All other business items, including the advisory vote on executive compensation, were also approved at the meeting [2] Company Overview - Precision Drilling is a leading provider of high-performance and environmentally responsible services to the energy industry, featuring an extensive fleet of Super Series drilling rigs [4] - The company has developed a digital technology portfolio known as Alpha™, which employs advanced automation software and analytics to enhance operational efficiency [4] - Precision also offers a suite of environmental solutions called EverGreen™, aimed at minimizing the environmental impact of its operations [4] - The company is headquartered in Calgary, Alberta, Canada, and is publicly traded on the Toronto Stock Exchange and the New York Stock Exchange under the symbols "PD" and "PDS" respectively [5]
PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update
GlobeNewswire News Room· 2025-05-14 11:30
Core Insights - PDS Biotechnology Corporation has initiated the VERSATILE-003 Phase 3 clinical trial for its investigational therapy Versamune® HPV targeting recurrent/metastatic HPV16-positive head and neck squamous carcinoma [4][9] - The company reported a net loss of approximately $8.5 million for Q1 2025, a decrease from $10.6 million in Q1 2024, attributed to lower operating expenses and increased tax benefits [6][7] - PDS Biotech's cash balance as of March 31, 2025, was $40 million, down from $41.7 million at the end of 2024 [8][15] Clinical Updates - The VERSATILE-003 trial is designed to include around 350 patients and is a two-arm controlled trial with a 2:1 randomization [6][4] - The primary endpoint of the trial is median overall survival, with interim readouts included in the study design [6][4] - The FDA has granted Fast Track designation for the combination of Versamune® HPV and pembrolizumab in treating recurrent/metastatic HNSCC [6][4] Financial Performance - Research and development expenses for Q1 2025 were $5.8 million, down from $6.7 million in Q1 2024, primarily due to reduced clinical trial expenses [7][6] - General and administrative expenses were slightly lower at $3.3 million for Q1 2025 compared to $3.4 million in Q1 2024 [7][6] - Total operating expenses decreased to $9.1 million in Q1 2025 from approximately $10.1 million in Q1 2024 [8][6] Corporate Developments - Three abstracts on Versamune® HPV were selected for presentation at the 2025 ASCO Annual Meeting scheduled for May 30-June 3, 2025 [6][4] - The company has entered into securities purchase agreements for the sale of 7,330,121 shares of common stock, raising approximately $11 million upon closing [6][4]